Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 8/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | HTR2A | P28223 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28599541 | 0.86 | SMPD1 (0.51) | SLC6A5MEN1KMT2ASMPD1TSHR | |
| SCHEMBL16015397 | 0.85 | LMNA (0.47) | SLC6A5MAPTSMN1; SMN2NPC1LMNA | |
| SCHEMBL969363 | 0.85 | SMPD1 (0.53) | SLC6A5MEN1KMT2AMAPTLMNA | |
| SCHEMBL28949956 | 0.85 | SMPD1 (0.53) | SLC6A5MEN1KMT2AMAPTLMNA | |
| SCHEMBL6111633 | 0.85 | SMPD1 (0.53) | SLC6A5MEN1KMT2AMAPTLMNA | |
| SCHEMBL969081 | 0.85 | SMPD1 (0.53) | SLC6A5MEN1KMT2AMAPTLMNA | |
| SCHEMBL10822340 | 0.82 | SLC6A5 (0.63) | SLC6A5ALDH1A1MAPTKDM4EHTR2A | |
| SCHEMBL19549597 | 0.81 | SMPD1 (0.46) | LMNASMPD1TSHR | |
| SCHEMBL13837233 | 0.80 | PLA2G2A (0.55) | ALDH1A1TSHR | |
| SCHEMBL10822455 | 0.77 | SLC6A5 (0.57) | SLC6A5MEN1KMT2AMAPTHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9201001-B2 | Visual detection of fluoride ions | INDIAN INSTITUTE OF TECHNOLOGY MADRAS (IN) | 2015-12-01 | — | — | US | disclosed |
| US-20140357894-A1 | VISUAL DETECTION OF FLUORIDE IONS | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2014-12-04 | — | — | US | disclosed |
| US-8828735-B2 | Visual detection of fluoride ions | INDIAN INSTITUTE OF TECHNOLOGY MADRAS (IN) | 2014-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140357894-A1 | VISUAL DETECTION OF FLUORIDE IONS | HNRNPL, HNRNPLL, ARAF | SLC6A5 3385/4885MEN1 3189/4885KMT2A 1693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.